Bempedoic acid and PCSK9 inhibitor eligibility in a contemporary population with atherosclerotic cardiovascular disease
7 April 2022 (09:30 - 14:00)
Organised by:
About the speaker
Mater Misericordiae University Hospital, Dublin (Ireland)
282 More presentations in this session
Miss C. Chaudron (Montpellier, FR)
Professor P. Jankowski (Warsaw, PL)
Access the full session
The Event
ESC Preventive Cardiology 2022
7 April - 9 April 2022
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
